Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AMED CoROCO:7575 -2.03%52 Days Payable is 28.75 as of Dec. 2025, which is 38% below its 10-year median of 46.53. GuruFocus rates ROCO:7575 with a GF Score™ of 52/100 and a GF Value™ of NT$62.73 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 796 Medical Devices & Instruments companies, AMED Co ranks worse than 67.59% on this metric.
AMED Co's average Accounts Payable for the
six
months ended in Dec. 2025 was NT$21.2 Mil. AMED Co's Cost of Goods Sold for the
six
months ended in Dec. 2025 was NT$134.9 Mil.
Hence, AMED Co's Days Payable for the
six
months ended in Dec. 2025 was 28.75.
The historical rank and industry rank for AMED Co's Days Payable or its related term are showing as below:
ROCO:7575'
s Days Payable Range Over the Past 10 Years
Min: 27.47 Med: 46.53 Max: 56.77
Current: 48.36
During the past 7 years, AMED Co's highest Days Payable was 56.77. The lowest was 27.47. And the median was 46.53.
ROCO:7575's Days Payable is ranked worse than 67.59% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs ROCO:7575: 48.36
AMED Co's Days Payable
declined
from Dec. 2024 (59.08) to Dec. 2025 (28.75).
It may suggest that AMED Coaccelerated paying its suppliers.
AMED Co Days Payable Related Terms
AMED Co Days Payable Historical Data
* Premium members only.
The historical data trend for AMED Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7575 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, AMED Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMED Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Days Payable distribution charts can be found below:
* The bar in red indicates where AMED Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
AMED Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMED Co (ROCO:7575) has a Days Payable of 28.75 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AMED Co and its competitors. This is 38% below median its historical median of 46.53. Over the past decade, AMED Co's Days Payable has ranged from 27.47 to 56.77. According to the industry distribution chart, AMED Co ranks #538 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 67.6%.
Is AMED Co's Days Payable too high?
AMED Co's current Days Payable of 28.75 is 38% below median its 10-year median of 46.53. Over the past 10 years, this metric has ranged from a low of 27.47 to a high of 56.77. The Medical Devices & Instruments industry median Days Payable is 67.97. AMED Co's value of 28.75 is 57.7% below this industry median. Based on the distribution chart, AMED Co ranks #538 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AMED Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AMED Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AMED Co ranks #538 out of 796 companies for Days Payable. This places AMED Co in the lower half of its industry. The industry median Days Payable is 67.97. AMED Co's value of 28.75 is 57.7% below this benchmark. Historically, AMED Co's own Days Payable has ranged from 27.47 to 56.77 over the past decade. While the company's 10-year median is 46.53 vs. the industry median of 67.97, AMED Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AMED Co's current Days Payable of 28.75 is 57.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AMED Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMED Co's current Days Payable is 28.75, which is 38% below median its own 10-year median of 46.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMED Co stock overvalued right now?
Based on GuruFocus' analysis, AMED Co (ROCO:7575) is currently considered Possible Value Trap. The stock's GF Value™ is NT$62.73, compared to a current price of NT$16.85 — trading 73.1% below its estimated fair value. The current Days Payable is 28.75, which is 38% below median its 10-year median of 46.53 and 57.7% below the Medical Devices & Instruments industry median of 67.97. AMED Co's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For AMED Co (ROCO:7575), the current Days Payable is 28.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMED Co (ROCO:7575) Overvalued in 2026?
Based on GuruFocus' analysis, AMED Co stock appears to be undervalued.
The current stock price of NT$16.85 is trading 73.1% below its estimated GF Value™ of NT$62.73.
GuruFocus considers AMED Co to be Possible Value Trap.
Key valuation signals for ROCO:7575:
Days Payable: 28.75 (38% below median its 10-year median of 46.53)
GF Value™: NT$62.73 vs. price of NT$16.85 (73.1% below fair value)
Industry Position: 57.7% below the Medical Devices & Instruments median (#538 of 796)
No single metric tells the full story. See the ROCO:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
52GF Score
Get the complete analysis for ROCO:7575
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7575 has been successfully added to your 
